Your browser doesn't support javascript.
loading
Inhibiting nonhomologous end-joining repair would promote the antitumor activity of gemcitabine in nonsmall cell lung cancer cell lines.
Guo, Nannan; Li, Shaojun; Liu, Bo; Chen, Ping; Li, Jingbo; Zhao, Yunlong; Zhao, Yingnan; Tang, Jian; Zhang, Wen.
Afiliación
  • Guo N; Department of Thoracic Surgery, The Fourth Medical Center of Chinese PLA General Hospital, Beijing.
  • Li S; Department of Thoracic Surgery, The Fourth Medical Center of Chinese PLA General Hospital, Beijing.
  • Liu B; Department of Thoracic Surgery, The Fourth Medical Center of Chinese PLA General Hospital, Beijing.
  • Chen P; Department of Thoracic Surgery, The Fourth Medical Center of Chinese PLA General Hospital, Beijing.
  • Li J; Department of Thoracic Surgery, The Fourth Medical Center of Chinese PLA General Hospital, Beijing.
  • Zhao Y; Department of Thoracic Surgery, The Fourth Medical Center of Chinese PLA General Hospital, Beijing.
  • Zhao Y; Department of Thoracic Surgery, The Fourth Medical Center of Chinese PLA General Hospital, Beijing.
  • Tang J; Department of Thoracic Surgery, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
  • Zhang W; Department of Thoracic Surgery, The Fourth Medical Center of Chinese PLA General Hospital, Beijing.
Anticancer Drugs ; 33(5): 502-508, 2022 06 01.
Article en En | MEDLINE | ID: mdl-35276695
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article